CRISPR
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CRSP Key Statistics
Stock Snapshot
With a market cap of 5.69B, CRISPR(CRSP) trades at $59.33. The stock has a price-to-earnings ratio of -8.91.
On 2026-03-04, CRISPR(CRSP) stock traded between a low of $57.75 and a high of $59.50. Shares are currently priced at $59.33, which is +2.7% above the low and -0.3% below the high.
The CRISPR(CRSP)'s current trading volume is 147.51K, compared to an average daily volume of 1.59M.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
CRSP News
Crispr Therapeutics AG ( (CRSP) ) has risen by 11.41%. Read on to learn why. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful investing...
CRISPR Therapeutics AG (NASDAQ:CRSP) shares jumped on Thursday, building on its Feb. 13 earnings report that showed growing momentum for its lead gene therapy a...
Analyst ratings
59%
of 29 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.